CLYM
Climb Bio
$14.95
−$0.10 (−0.66%)Sep 10, 2026
Key metrics
The numbers that frame CLYM today
- Market cap
- $858.67M
- P/E (TTM)
- -14.9
- EV / FCF
- -15.4
- ROIC
- -37.4%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.54
- 52wk High
- $18.33
Growth
Revenue and earnings trend for CLYM
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CLYM
Is Climb Bio a good buy?
Hold. Climb Bio has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Climb Bio is selling at a high price.
What is the market capitalization of CLYM?
Climb Bio's market capitalization is $858.67M.
What is the P/E ratio for CLYM stock?
Climb Bio's current P/E ratio is -14.9.
What is the 52-week high for CLYM stock?
The 52-week high for Climb Bio is $18.33. The current close of $14.95 is 18.4% below that high.
What is the 52-week low for CLYM stock?
The 52-week low for Climb Bio is $1.54. The current close of $14.95 is 870.8% above that low.
Does CLYM stock pay dividends?
Climb Bio does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CLYM?
Climb Bio's Debt / Equity ratio is 0.01.